Myra Raney @myralynnr
29 December, 05:16
A 2025 experimental study in Nature revealed how aspirin can suppress cancer metastasis.
Platelets release thromboxane A2 (TXA2), which binds CD8+ T cells and activates ARHGEF1, suppressing T-cell function and preventing immune-mediated tumor clearance.
Researchers used mouse models of melanoma and lung cancer, showing that blocking platelet COX-1 with aspirin or deleting ARHGEF1 in T cells reactivated cytotoxic T cells, dramatically reducing metastases. This effect was immune-dependent: mice lacking functional T cells showed no benefit.
These findings provide a mechanistic explanation for decades of clinical observations linking low-dose aspirin to reduced cancer spread. Targeting the TXA2–COX-1–ARHGEF1 axis may guide future immunotherapies against metastasis.

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Myra Raney @myralynnr
Bottom Fact : Aspirin reduces cancer metastasis by blocking platelet TXA2, lifting T-cell suppression, and restoring immune-mediated tumor cell killing in preclinical models.
Source : Nature (2025) Experimental study on platelet-mediated immune suppression and aspirin in mouse cancer models
Disclaimer : This content is for educational purposes. Findings are preclinical; aspirin’s effects in humans for metastasis prevention require clinical confirmation and professional medical guidance.
05:17 AM - Dec 29, 2025
In response Myra Raney to her Publication
Only people mentioned by myralynnr in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Myra Raney, click on at the bottom under it